D-0037-2027 Class II Ongoing
FDA drug recall D-0037-2027 was initiated by Apothecary Pharma LLC on Sep 24, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 1 vial.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 14, 2026
- Initiation Date
- Sep 24, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1 vial
Product description
Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06.
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
Nationwide within the United States
Code information
Lot #: AP-202647, BUD 13-Oct-2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0037-2027
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026